Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Psychopharmacology

• Publication date

  1997-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s002130050322PMID 9272762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes

  2005cited by this paper
• Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat

  2005cited by this paper
• Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat

  2005cited by this paper
• Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia

  2005cited by this paper
• Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine

  2005cited by this paper
• Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia

  2004cited by this paper
• Tolerability of long term clozapine treatment

  2004cited by this paper
• Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity

  2004cited by this paper
• Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats

  2004cited by this paper
• D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

  2004cited by this paper
• Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats

  2004cited by this paper
• Biochemical and behavioural properties of clozapine

  2004cited by this paper
• Effect of a cholinomimetric drug (RS 86) in tardive dyskinesia and drug-related parkinsonism

  2004cited by this paper
• Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

  2004cited by this paper
• Acute dystonia induced by neuroleptic drugs

  2004cited by this paper
• Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat

  2004cited by this paper
• Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats

  2004cited by this paper
• Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs.

  1997cited by this paper
• Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions.

  1997cited by this paper
• Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects.

  1997cited by this paper
• Drugs and the treatment of psychiatric disorders

  1996cited by this paper
• Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor.

  1996cited by this paper
• Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements.

  1996cited by this paper
• Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure

  1996cited by this paper
• Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

  1996cited by this paper
• Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective “D1-like” dopamine receptor agonist A 68930 and selective “D2-like” agonist RU 24213

  1996cited by this paper
• Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol

  1996cited by this paper
• D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

  1995cited by this paper
• Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats.

  1995influential reference
• Conventional antipsychotic medications for schizophrenia.

  1995cited by this paper
• Risperidone: efficacy and safety.

  1995cited by this paper
• Clozapine: efficacy and safety.

  1995cited by this paper
• Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs

  1994cited by this paper
• The involvement of nucleus accumbens dopamine in appetitive and aversive motivation.

  1994cited by this paper
• Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats.

  1994influential reference
• Differential effects of clozapine and pimozide on fixed-ratio responding during repeated dosing.

  1994influential reference
• Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.

  1994cited by this paper
• The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat.

  1994cited by this paper
• Unlike haloperidol, clozapine slows and dampens rats' forelimb force oscillations and decreases force output in a press-while-licking behavioral task

  1994cited by this paper
• Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding.

  1994cited by this paper
• Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.

  1993cited by this paper
• Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo.

  1993cited by this paper
• Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.

  1993cited by this paper
• Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine.

  1993cited by this paper
• Modulatory effect of clozapine on levodopa response in parkinson's disease: A preliminary study

  1993influential reference
• Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics.

  1993influential reference
• Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats.

  1993cited by this paper
• Exacerbation of parkinsonism by tacrine.

  1992cited by this paper
• The mesolimbic dopamine system: From motivation to action

  1991influential reference
• Update on the clinical efficacy and side effects of clozapine.

  1991influential reference
• Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms

  1991influential reference
• Treatment of parkinsonian tremor with clozapine

  1990cited by this paper
• Clozapine‐responsive tremor in Parkinson's disease

  1990influential reference
• Tardive Meige syndrome responsive to clozapine.

  1990cited by this paper
• Clozapine in idiopathic Parkinson's disease

  1990cited by this paper
• The effect of long‐term treatment with clozapine in schizophrenia: A retrospective study in 96 patients treated with clozapine for up to 13 years

  1988cited by this paper
• Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT.

  1987cited by this paper
• The Actions of Neuroleptic Drugs on Appetitive Instrumental Behaviors

  1987cited by this paper
• Clozapine in the treatment of tremor

  1986cited by this paper
• Dose-dependent increases in rat spontaneous chewing rates during long-term administration of haloperidol but not clozapine

  1986influential reference
• Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat

  1986cited by this paper
• Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration.

  1986cited by this paper
• Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease.

  1984cited by this paper
• The Clinical Use of Anticholinergic Drugs As Treatment for Extrapyramidal Side Effects of Neuroleptic Drugs

  1983cited by this paper
• Neuroleptic‐Induced Extrapyramidal Reactions: Classification, Description, and Diagnosis

  1983cited by this paper
• Physostigmine test in the rabbit syndrome and tardive dyskinesia.

  1980cited by this paper
• Antipsychotic drug doses and neuroleptic/dopamine receptors

  1976cited by this paper
• Drugs, neurotransmitters, and schizophrenia.

  1974cited by this paper
• Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

  1974cited by this paper
• Cholinergic-anticholinergic antagonism in parkinsonism.

  1967cited by this paper

• Targeting the serotonergic system in the treatment of neurodegenerative diseases—emerging therapies and unmet challenges

  2025cites this paper
• Movement disorders associated with acetylcholinesterase inhibitors in Alzheimer’s dementia: A systematic review

  2025cites this paper
• Chemogenetic activation of ventral tegmental area GABA neurons, but not mesoaccumbal GABA terminals, disrupts responding to reward-predictive cues

  2018cites this paper
• Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.

  2011cites this paper
• Effects of Risperidone on Learning and Memory in Naive and MK-801-Treated Rats

  2011influential citation
• Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons

  2011cites this paper
• The serotonergic system in Parkinson's disease.

  2011cites this paper
• Relative bioavailability and pharmacokinetic comparison of two 2-mg risperidone tablet formulations: A single dose, randomized-sequence, double-blind, 2-way crossover study in healthy male volunteers in Thailand.

  2010cites this paper
• A correlation of haloperidol-induced cognitive deficit with dysfunctional dopamine receptor activity in nonhuman primate

  2010cites this paper
• Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats

  2010cites this paper
• Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders.

  2010cites this paper
• Regional Differences in the Action of Antipsychotic Drugs: Implications for Cognitive Effects in Schizophrenic Patients

  2010influential citation
• Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.

  2009cites this paper
• The effect of exposure to drugs on the processing of natural rewards.

  2009influential citation
• A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model.

  2008cites this paper
• Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.

  2008cites this paper
• Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.

  2008cites this paper
• Adenosine A2A receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing

  2007influential citation
• The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors

  2007cites this paper
• Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.

  2007cites this paper
• Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies?

  2006cites this paper
• Effects of baclofen on reserpine-induced vacuous chewing movements in mice.

  2006cites this paper
• Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.

  2005cites this paper
• Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats.

  2005cites this paper
• Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.

  2005cites this paper
• Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats

  2005cites this paper
• Evidence for the involvement of central serotonergic mechanisms in cholinergic tremor induced by tacrine in Balb/c mice.

  2005cites this paper
• Haloperidol versus risperidone on rat "early onset" vacuous chewing.

  2004cites this paper
• Prediction of Comorbid Alcohol Use Disorders Using Factors Derived from the Positive and Negative Syndrome Scale in an Inpatient Psychiatric Hospital

  2004cites this paper
• Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats.

  2003cites this paper
• The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats.

  2002cites this paper
• Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats

  2002cites this paper
• Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor

  2002influential citation
• Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease

  2002cites this paper
• Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat

  2001cites this paper
• Histamine Infusion Induces a Selective Dopaminergic Neuronal Death Along with an Inflammatory Reaction in Rat Substantia Nigra

  2000cites this paper
• Clozapine-like motor effects of the atypical antipsychotic risperidone in rats.

  2000cites this paper
• Effects of serotoninergic drugs on tremor induced by physostigmine in rats.

  2000cites this paper
• Effects of H1 antagonists on cholinomimetic-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine.

  2000cites this paper
• Behavioral assessment of atypical antipsychotics in rats: studies of the effects of olanzapine (Zyprexa)

  1999cites this paper
• Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats

  1999cites this paper
• The effect of novel antipsychotics in rat oral dyskinesia.

  1999cites this paper
• Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat

  1998cites this paper
• Tremulous jaw movements in rats: a model of parkinsonian tremor.

  1998cites this paper
• Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats.

  1997cites this paper